Рациональная фармакотерапия в кардиологии
Т. 15, Вып. 6, С. 779-788
Аннотация:
Aim. To study the clinical outcomes (achievement of target blood pressure [BP]) and tolerability of antihypertensive and hypolipidemic therapy with fixed combinations of indapamide/perindopril, amlodipine/perindopril, amlodipine/indapamide/perindopril and rosuvastatin in patients with hypertension and high/very high cardiovascular risk in real clinical practice. Material and methods. The study included 16,788 patients from 104 cities of the Russian Federation. The duration of observation was 12 weeks. All patients had three monitoring visits. BP level was measured twice during the visits: the arithmetic mean of the obtained parameters was calculated. The results of the study were analyzed and presented by descriptive statistics. Results. The average age of the patients was 60.6±10.2 years; 42.2[%] of the patients were men and 57.8[%] women. Patients who demonstrated systolic-diastolic hypertension (BP>140/90 mm Hg) at the initial visit accounted for 73.9[%] (n=12,413) of the total number of
Ключевые слова:
Epidemiology; Fixed combinations; Hypertension; Perindopril; Target blood pressure
amlodipine plus indapamide plus perindopril; amlodipine plus perindopril; indapamide plus perindopril; rosuvastatin; adult; antihypertensive therapy; arithmetic; Article; blood pressure; blood pressure monitoring; cardiovascular risk; clinical outcome; clinical practice; clinical trial; combination drug therapy; diastolic blood pressure; drug efficacy; drug tolerability; female; human; hypertension; hypertensive patient; major clinical study; male; medication compliance; middle aged; monotherapy; Russian Federation; systolic blood pressure; treatment duration; unspecified side effect
Напалков Д. А.
Napalkov D. A.
Russian trial algorithm: Implementation of combined antihypertensive and hypolipidemic treatment for clinical efficacy achievement in routine clinical practice [Российская наблюдательная программа АЛГОРИТМ: реализация идеи комбинированной антигипертензивной и гиполипидемической терапии для достижения клинического результата в рутинной клинической практике]
Russian trial algorithm: Implementation of combined antihypertensive and hypolipidemic treatment for clinical efficacy achievement in routine...
Текст визуальный непосредственный
Рациональная фармакотерапия в кардиологии
Столичная издательская компания
Т. 15, Вып. 6 С. 779-788
2019
Статья
Epidemiology Fixed combinations Hypertension Perindopril Target blood pressure
amlodipine plus indapamide plus perindopril amlodipine plus perindopril indapamide plus perindopril rosuvastatin adult antihypertensive therapy arithmetic Article blood pressure blood pressure monitoring cardiovascular risk clinical outcome clinical practice clinical trial combination drug therapy diastolic blood pressure drug efficacy drug tolerability female human hypertension hypertensive patient major clinical study male medication compliance middle aged monotherapy Russian Federation systolic blood pressure treatment duration unspecified side effect
Aim. To study the clinical outcomes (achievement of target blood pressure [BP]) and tolerability of antihypertensive and hypolipidemic therapy with fixed combinations of indapamide/perindopril, amlodipine/perindopril, amlodipine/indapamide/perindopril and rosuvastatin in patients with hypertension and high/very high cardiovascular risk in real clinical practice. Material and methods. The study included 16,788 patients from 104 cities of the Russian Federation. The duration of observation was 12 weeks. All patients had three monitoring visits. BP level was measured twice during the visits: the arithmetic mean of the obtained parameters was calculated. The results of the study were analyzed and presented by descriptive statistics. Results. The average age of the patients was 60.6±10.2 years; 42.2[%] of the patients were men and 57.8[%] women. Patients who demonstrated systolic-diastolic hypertension (BP>140/90 mm Hg) at the initial visit accounted for 73.9[%] (n=12,413) of the total number of